ATP gamma-p-azidoanilide: photoaffinity label
ID Source | ID |
---|---|
PubMed CID | 3035480 |
CHEMBL ID | 558335 |
MeSH ID | M0082391 |
Synonym |
---|
adenosine triphosphate gamma-p-azidoanilide |
CHEMBL558335 |
[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-n-(4-azidophenyl)phosphonamidic acid |
atp-gamma-4-azidoanilide |
gamma-(p-azidoanilide)atp |
54687-13-7 |
adenosine 5'-(trihydrogen diphosphate) monoanhydride with (4-azidophenyl)phosphoramidic acid |
atp gamma-p-azidoanilide |
DTXSID70203142 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID432090 | Effect on wild type recombinant CDK2/cyclin E1 assessed as p27kip1 phosphorylation after 1 hr by immunoblot analysis | 2009 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 19, Issue:14 | Synthesis and reactivity of novel gamma-phosphate modified ATP analogues. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |